sales@contrivedatuminsights.com
CDI - Contrive Datum Insights

Menstrual Cup MarketSize, Share & Industry Analysis, 2026-2034By MaterialBy SizeBy UsabilityBy ShapeBy Distribution Channel

Full title & scope — all 5 axes with their segments

Menstrual Cup Market Size, Share & Industry Analysis, By Material (Silicone, Thermoplastic Isomer, Rubber, Latex), By Size (Small, Large), By Usability (Reusable, Disposable), By Shape (Round, Hollow, Pointy, Flat), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), and Regional Forecast, 2026-2034

Last Updated: Sep 21, 2026Report ID: CDI-248381
Methodology

How the estimates were built: data sources, modelling approach and validation steps.

Research approach

A market size is a claim about the world, and a claim is only as good as the route to it. Every study is built upward from units and prices — what is actually produced, sold or performed, at what it actually changes hands for — rather than from a headline figure divided downwards. Disclosed company revenue is then used to check that build, not to produce it.

Market size estimation, this report

The market was built upward from unit volumes, not assumed from a stated growth rate. Country level cup sales were estimated from the female population of reproductive age, cup penetration relative to tampons and pads, and an average replacement cycle of one to three years reflecting how long a single silicone cup stays in use before a buyer replaces it. Those unit estimates were carried forward with realized average selling prices across the hospital pharmacy, retail pharmacy and online pharmacy channels, since direct to consumer online pricing runs well above mass retail pricing. The resulting build was then checked against disclosed and estimated revenue from named manufacturers; where the two diverged, the replacement cycle or penetration assumption feeding the build was corrected.

The four stages

The same sequence runs behind every published study, whatever the industry. The order matters as much as the steps: the segment axes are fixed before any number is collected, so the model is never reshaped to fit whatever data happens to turn up.

1
Scope and segmentation
2
Bottom-up sizing
3
Reconciliation
4
Forecast

What the build rests on, and what checks it

The two are not interchangeable. The left column produces the number; the right column tests it. When the check disagrees with the build, the answer is to find which bottom-up assumption is wrong — a unit count, a price, a take-up rate — not to split the difference between them.

The bottom-up build rests on
  • Volume actually transacted — units produced, installed, dispensed or procedures performed, counted at the level each is genuinely recorded
  • Realised pricing by tier and channel, rather than one blended average applied across the whole market
  • Take-up and frequency: how much of the addressable base buys, and how often it repeats
The build is checked against
  • Disclosed revenue of the companies serving the market, where filings separate it far enough to be usable
  • Buyer-side spending totals — capital budgets, procurement lines, or the output of the end market the product is bought against
  • Trade and customs flows, where the product crosses borders in a separately recorded form
Bottom-up sequence
1
Size the base
2
Apply take-up
3
Apply frequency
4
Apply realised price
Reconciliation sequence
1
Gather disclosed revenue
2
Strip out-of-scope lines
3
Compare against the build
4
Correct the assumption

Data sources

Published data establishes what happened. Only the people transacting in a market can say why, and what is about to change — so the two are collected separately and weighted differently.

Primary — who is interviewed
  • Commercial and product leadership at the companies that supply the market
  • Procurement and specification leads at the organisations that buy it
  • Distributors, integrators and channel partners, where the market is served indirectly
  • Regulatory and standards specialists, where approval governs what can be sold at all
Secondary — what is read
  • Company filings, annual reports and investor disclosure
  • Government statistics, customs records and regulatory registers
  • Trade association output and standards-body publications
  • Technical and peer-reviewed literature, where the market rests on a clinical or engineering claim
Primary research design, this report

Primary outreach targeted category managers and buyers at pharmacy and mass retail chains, regulatory affairs contacts at cup manufacturers responsible for medical device or cosmetic registrations, and commercial leads at direct to consumer brands who can speak to online conversion and repeat purchase behavior. Distributor and wholesale contacts in Latin America, the Middle East and Africa received particular emphasis because disclosed company revenue is thinnest in those regions, while North America and Europe sampling leaned toward retail buyers who can speak to shelf space and assortment decisions across established chains.

Secondary sources, this report

Desk research drew on national and regional device or cosmetic registers that list menstrual cups where a jurisdiction requires registration, customs trade data filed under the personal hygiene product codes cups are typically classified within, and benchmarks published by feminine hygiene trade associations active in Europe and North America. Company filings and investor materials from the publicly listed hygiene product makers active in this market were reviewed for disclosed revenue by product line, and program documentation published by public health agencies and NGOs was used to estimate distributed, non retail cup volumes in program funded markets.

Desk research runs across proprietary research databases including Factiva, OneSource and Hoovers alongside the public sources above. Modelling and statistical validation are run in SAS and SPSS.

Forecasting

The forecast is not a growth rate applied to a base year. It is built from the drivers that are expected to change, each one stated so a reader can disagree with it.

Forecast approach, this report

The forecast carries forward the shift from absorbent products toward reusable cups observed in the historical period, moderated by channel specific adoption curves instead of one blended rate applied everywhere. Online pharmacy volume is modeled to keep gaining share as direct to consumer marketing lowers the barrier to a first purchase, while hospital pharmacy volume is held largely flat since clinical distribution has never been a meaningful channel for this category. Government and NGO menstrual health programs are treated as an incremental volume source concentrated in Asia Pacific, Latin America and Africa, not a uniform global effect. The forecast holds only if reusable products keep gaining share against pads and tampons at a pace close to the historical trend.

Triangulation and validation

No figure enters a report on the strength of one source. Where the two sizing routes disagree the difference is not averaged away — the assumption causing it is isolated, tested against a third independent measure, and either corrected or carried forward as a stated limitation. Historical years are back-tested against the growth actually recorded before any forecast is allowed to run forward from them.

Validation, this report

The historical build was back tested against year over year growth implied by the disclosed revenue of manufacturers with public financials, and the segment level shifts, particularly silicone gaining share from rubber and latex and online pharmacy gaining share from retail pharmacy, were reviewed with category buyers who confirmed the direction even where they could not confirm the exact magnitude. Sensitivities were run on the replacement cycle assumption and on the pace of online channel share gain, since those two inputs move the forecast total more than any other single assumption in the build.

Confidence and limitations

Where an estimate is firm and where it is not is stated rather than left to be inferred from the precision of the number.

Confidence framing, this report

Confidence is firmer for the material and distribution channel splits, where disclosed manufacturer revenue and channel pricing data both exist to check the build. It is thinner for the shape based segmentation, where sales are rarely reported by product design and the split rests more on retailer assortment data than on company disclosure, and for the Middle East and Africa region, where program distributed volume is estimated from budget figures, not counted unit by unit. A structural risk to the forecast is a faster than expected move to online only distribution, which would compress retail pharmacy revenue faster than modeled here.

Scope

Questions This Report Answers

6 questions
01

What is the market size and growth rate, globally and by region?

02

How is the market segmented, and which segments lead?

03

Which regions and countries are covered, and how do they compare?

04

What are the key drivers, restraints, opportunities and challenges?

05

Who are the leading companies operating in this market?

06

What trends are expected to shape the market through the forecast period?

Questions

Frequently Asked Questions

01What is the Menstrual Cup Market projected to reach?

USD 2200 Million by 2034, CAGR 8.5%

02What years does this report cover?

Study period 2020–2034, base year 2025, historical data 2020-2024, forecast period 2026-2034.

03Which regions are covered?

North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

04Which region accounted for the largest market share?

North America leads with 32% of global revenue through 2034.

05Which segment leads the market?

Silicone is the largest line by Material, at 68% of revenue in 2025.

06Who are the key companies profiled?

Blossom Cup, Diva International Inc, Fleurcup, INTIMINA, Jaguara s.r.o. (LadyCup), Lena Cup LLC, Silky Cup, Chemco Group, Mooncup Ltd, The Flex Company, Me Luna Gmbh, Soch Green, Procter and Gamble, The Keeper, Inc.. Full profiles are part of the paid report.

07Can the segmentation be customized?

Yes. Custom data cuts by geography, segment, or competitor set are available on request.

425+
Dedicated research analysts
1,200+
Reports published
Why CDI

Why choose CDI

Data triangulated across primary and secondary sources
Complimentary analyst call included with every purchase
Custom data cuts and post-purchase support available

Need this report shaped around your question?

The scope isn't fixed. Tell us what your team needs that the standard edition doesn't cover, and an analyst will come back on what can be adjusted and how long it takes, before you commit to anything.

Most licences include 3060 hours of customization at no extra cost. See what each licence includes

Request customization

Additional Companies

Add competitors, suppliers or the peer set you benchmark against to the companies already covered.

Deeper Competitive View

Sharpen the landscape work around your own position: product line, channel, or a named shortlist of rivals.

Extra Segment Splits

Break the market down along an axis the standard scope doesn't cut it by, or go a level deeper inside one.

Application Focus

Narrow the analysis to the specific use cases and end users your team actually sells into.

Different Time Frame

Move the base year, or widen the historical and forecast windows the study is built on.

Country-Level Detail

Go below region level into the individual countries that matter to you, rather than the standard geography split.